國家衛生研究院 NHRI:Item 3990099045/8369
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 914743      在线人数 : 1404
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/8369


    题名: The response of patients with epstein-barr virus - associated hemophagocytic lymphohistiocytosis to HLH-2004 protocol in the initial therapy
    作者: My, LT;Lien, LB;Hung, NT;Thuong, TC;Tuan, NM;Nhan, NT;Thinh, LQ;Dao, NTH;Le, DTM;Tung, TT;Anh, NHM;Anh, TNK;Anh, PNL;Khanh, LTX;Huong, PLM;Van, LT;An, DTT;Su, IJ
    贡献者: Division of Infectious Diseases
    摘要: Purpose: To determine the rate of response of patients with Epstein Barr virus(EBV)associated HLH (hemophagocytic lymphohistiocytosis) to HLH 2004 protocol, and to evaluate the courses of clinical signs as well as laboratory data during the first 8 weeks of therapy. Methods: This was a prospective case series report consisting of 13 patients younger than 16 years old, diagnosed with EBV associated HLH and admitted to the Children Hospital 1 in HCMC from August 1st, 2011 to May 31st, 2012. Results: Of these patients, 54% (7/13) were classified as response group, 23% (3/13) as non response group and 23% (3/13) as mortality group. The median (range) of EBV DNA loads in plasma of the mortality group, non response group and response group were respectively 7.3 x 107.2 copies/ml (7.0 – 7.3 x107.2 copies/ml), 6.9 x107.2 copies/ml (5.7 – 7.5 x107.2 copies/ml) and 5.0x107.2 copies/ml (2.7 – 7.3 x 107.2 copies/ml). Immunochemotherapy were used as followed: dexamethasone in 100% (13/13) cases, cyclosporine A in 100% (13/13) cases, etoposide in 46% (6/13) cases and IVIg in 76% (10/13) cases. In the mortality group, dexamethasone, cyclosporine A and IVIg were given in 100% (3/3) cases, but etoposide was not used for any patients. The median time of treatment in the mortality group was only 7 days (7 – 15 days), in the non response group was 273 days (203 – 287 days) and in the response group was 224 days (182 – 329 days). Ferritinemia and triglyceridemia returned to the normal range after the 4th week of treatment in the response group, but still remained at a high level until the 8th week of treatment in the non response group. The EBV DNA load of the response group was below the detection limit in the second week of treatment, but still high in the non response and the mortality group.
    日期: 2014-11
    關聯: Pediatric Blood and Cancer. 2014 Nov;61(11):2134-2135.
    Link to: http://dx.doi.org/10.1002/pbc.25097
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1545-5009&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000342723300075
    显示于类别:[蘇益仁(2002-2015)] 會議論文/會議摘要

    文件中的档案:

    档案 描述 大小格式浏览次数
    ISI000342723300075.pdf51KbAdobe PDF581检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈